| Ytd | -64.47% | |
| 1y | -64.47% |
| Open | 2.65 | Prev Close | 2.66 | Low | 2.59 | High | 2.71 | Mkt Cap | 17.00M |
| Vol | 28.07K | Avg Vol | 1.41M | EPS | -0.83 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.72 | 200-d Avg | 4.18 | 1yr Est | 0.00 |
Pulsenmore (NASDAQ:PLSM) reported quarterly losses of $(1.83) per share. The company reported $2.04
Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update OMER,
OMER, Israel, Aug. 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a leading i
The Company's home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at
The new grant brings the total AI grants approved for Pulsenmore over the past month to approximatel
Gainers Pulsenmore (NASDAQ:PLSM) shares increased by 171.2% to $10.47 during Monday's pre-marke
The program is designed to enable Pulsenmore to develop and clinically validate AI applications that
The program is designed to enable Pulsenmore to develop and clinically validate AI applications that
Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m
Pulsenmore (NASDAQ: PLSM) stock dips premarket after announcing a $7.5M private placement to fund it
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
RAMAT GAN, Israel, June 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pion
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg
U.S. stocks rise with Dow gaining over 400 points. Energy stocks fall while healthcare shares surge.
US stocks higher, Nasdaq up 100 pts. Dow up 0.07%, Nasdaq up 0.52%, S&P 500 up 0.45%. Consumer d
PLSM stock surges over 200% premarket as Pulsenmore partners with Ouma Health to bring FDA-authorize
Gainers Pulsenmore (NASDAQ:PLSM) stock increased by 152.0% to $8.59 during Wednesday's pre-mark
Through the collaboration, Ouma Health will incorporate Pulsenmore's FDA-authorized home ultraso
FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care
Pulsenmore (NASDAQ:PLSM) reported quarterly losses of $(0.77) per share. The company reported $12.5
Full-Year 2025 Financial HighlightsFull year revenue of $12.5 million, representing a 374% increase
Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Bus
OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer
OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in
Commercial agreement potentially valued at approximately $4.5 million over five years following 18 m
RAMAT GAN, Israel, Jan. 21, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pio